Breaking News Instant updates and real-time market news.

2020-05-01 10:52:09 SPGYF Whitecap Resources $0.00 / + (+0.00%) 10:52 05/01/20 05/01 10:52 05/01/20 10:52	CIBC still sees Whitecap as preferred stock in Canadian mid-cap oil space CIBC analyst Dave Popowich reiterated an Outperformer rating and C$3 price target on Whitecap Resources in the wake of the company's Q1 results. The analyst said he continues to see Whitecap as a preferred stock in the Canadian mid-cap oil space.
SPGYF Whitecap Resources $0.00 / + (+0.00%) 05/01/20 RBC Capital RBC encouraged by Whitecap's focus on cost-cutting initiatives 04/07/20 Scotiabank Whitecap Resources downgraded to Sector Perform from Outperform at Scotiabank 03/13/20 TD Securities Whitecap Resources price target lowered to C$2.50 from C$7 at TD Securities

2020-05-01 10:52:09

SPGYF

Whitecap Resources

$0.00 / + (+0.00%)

10:52

05/01/20

05/01

10:52

05/01/20

10:52

CIBC still sees Whitecap as preferred stock in Canadian mid-cap oil space

CIBC analyst Dave Popowich reiterated an Outperformer rating and C$3 price target on Whitecap Resources in the wake of the company's Q1 results. The analyst said he continues to see Whitecap as a preferred stock in the Canadian mid-cap oil space.

SPGYF Whitecap Resources

$0.00 / + (+0.00%)

05/01/20 RBC Capital: RBC encouraged by Whitecap's focus on cost-cutting initiatives

04/07/20 Scotiabank: Whitecap Resources downgraded to Sector Perform from Outperform at Scotiabank

03/13/20 TD Securities: Whitecap Resources price target lowered to C$2.50 from C$7 at TD Securities

TODAY'S FREE FLY STORIES

Recommendations	Wayfair price target raised to $250 from $230 at Citi » 06:18 03/02/21 03/02 06:18 03/02/21 06:18 W Wayfair $335.96 / +46.765 (+16.17%) Citi analyst Nicholas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options W Wayfair $335.96 / +46.765 (+16.17%) 02/25/21 Wayfair sees Q1 gross margin 26%-28% 02/25/21 Wayfair reports Q4 orders delivered 16.5M 01/07/21 Wayfair announces all U.S. employees to make at least $15 per hour 11/13/20 Wayfair appoints Johnson & Johnson CCO Michael Sneed to board W Wayfair $335.96 / +46.765 (+16.17%) 03/01/21 Fly Intel: Top five analyst upgrades 03/01/21 Truist Wayfair upgraded to Buy from Hold at Truist 03/01/21 Truist Wayfair upgraded to Buy from Hold at Truist 02/26/21 DA Davidson Wayfair price target raised to $326 from $280 at DA Davidson W Wayfair $335.96 / +46.765 (+16.17%) 02/25/21 Wayfair reports Q4 adjusted EPS $1.24, consensus 86c 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 11/03/20 Wayfair reports Q3 adjusted EPS $2.30, consensus 80c and ($2.23) last year W Wayfair $335.96 / +46.765 (+16.17%) 11/03/20 Hedgeye adds Wayfair to best idea short list, Bloomberg says 10/17/20 eBay going back to basics, Barron's says W Wayfair $335.96 / +46.765 (+16.17%) 03/01/21 Twitter, Wayfair upgrades among today's top calls on Wall Street 02/25/21 Fly Intel: Pre-market Movers 11/10/20 Square, Wayfair upgrades among today's top calls on Wall Street 11/03/20 Fly Intel: Wall Street's top stories for Tuesday W Wayfair $335.96 / +46.765 (+16.17%) 02/25/21 Unusually active option classes on open February 25th 01/22/21 Wayfair put volume heavy and directionally bearish 11/03/20 Unusually active option classes on open November 3rd
Hot Stocks	KVH Industries appoints Roger Kuebel as CFO » 06:17 03/02/21 03/02 06:17 03/02/21 06:17 KVHI KVH Industries $14.15 / +0.37 (+2.69%) , AZPN Aspen Technology $153.52 / +2.67 (+1.77%) KVH Industries (KVHI),… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events KVHI AZPN KVHI KVH Industries $14.15 / +0.37 (+2.69%) 01/19/21 KVH Industries partners with GreenSteam for KVH Watch maritime IoT solution 12/17/20 KVH Industries partners with ioCurrents for KVH Watch maritime IoT solution 12/10/20 KVH Industries expands mini-VSAT Broadband HTS network coverage 09/17/20 KVH Industries CFO Reilly to retire later this year AZPN Aspen Technology $153.52 / +2.67 (+1.77%) 02/08/21 Aspen Technology VP Hague sells over $503K in company shares 12/09/20 Aspen Technology acquires OptiPlant, terms undisclosed 11/17/20 Aspen Technology acquires Camo Analytics, terms undisclosed 11/16/20 Aspen Technology receives staff determination from Nasdaq KVHI AZPN KVHI KVH Industries $14.15 / +0.37 (+2.69%) AZPN Aspen Technology $153.52 / +2.67 (+1.77%) 02/16/21 KeyBanc Aspen Technology price target raised to $180 from $158 at KeyBanc 02/03/21 Baird Aspen Technology upgraded to Outperform from Neutral at Baird 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 09/23/20 BofA Aspen Technology reinstated with a Neutral at BofA KVHI AZPN KVHI KVH Industries $14.15 / +0.37 (+2.69%) 06:06 Today KVH Industries reports Q4 non-GAAP EPS 7c, consensus 2c 10/29/20 KVH Industries reports Q3 adj. cont. ops. EPS 6c, consensus (17c) AZPN Aspen Technology $153.52 / +2.67 (+1.77%) 01/27/21 Aspen Technology sees FY21 adjusted EPS $5.29-$5.58, consensus $5.00 01/27/21 Aspen Technology reports Q2 adjusted EPS $2.04, consensus $1.17 11/05/20 Aspen Technology backs FY21 adjusted EPS view $4.78-$5.32, consensus $5.01 09:00 Today KVH Industries - KVHI
Recommendations	OraSure price target lowered to $16 from $18 at Citi » 06:17 03/02/21 03/02 06:17 03/02/21 06:17 OSUR OraSure $11.08 / +0.42 (+3.94%) Citi analyst Patrick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options OSUR OraSure $11.08 / +0.42 (+3.94%) 01/29/21 OraSure's OM-505 saliva collection kit included in EUA granted to Ambry 01/28/21 OraSure's saliva collection device authorized by Health Canada for COVID-19 test 01/26/21 Chronomics selects OraSure's OMNIgene ORAL salive collection kit 01/21/21 OraSure's saliva collection kit Included in FDA authorization for exome platform OSUR OraSure $11.08 / +0.42 (+3.94%) 12/22/20 Lake Street Lake Street says OraSure test news disappointing, not due to fundamental issues 08/21/20 Fly Intel: Top five analyst initiations 08/21/20 Evercore ISI OraSure initiated with an Outperform at Evercore ISI 08/21/20 Evercore ISI OraSure initiated with an Outperform at Evercore ISI OSUR OraSure $11.08 / +0.42 (+3.94%) 03/01/21 OraSure reports Q4 EPS 3c, consensus 7c 11/04/20 OraSure reports Q EPS 1c, consensus (7c) 03 Jun OSUR OraSure $11.08 / +0.42 (+3.94%) 03/01/21 Fly Intel: After-Hours Movers 12/23/20 Fly Intel: Pre-market Movers 11/04/20 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: Pre-market Movers OSUR OraSure $11.08 / +0.42 (+3.94%) 11/04/20 OraSure options imply 19.8% move in share price post-earnings
Periodicals	AWS manager files discrimination lawsuit, Business Insider reports » 06:17 03/02/21 03/02 06:17 03/02/21 06:17 AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) A Black AWS manager is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 05:45 Today Amazon Web Services launches second region in Japan 05:19 Today Philips appoints Shez Partovi chief innovation and strategy officer 03/01/21 Amazon Prime Video, Eros STX Global confirm Nordics output deal 03/01/21 Verizon, NFL, AWS leverage 5G, MEC for mobile gaming at Super Bowl LV AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 02/26/21 B. Riley Securities Plug Power recent selloff provides relative discount, says B. Riley 02/17/21 Needham Kornit Digital price target raised to $125 from $76 at Needham 02/17/21 Morgan Stanley Roku price target raised to $275 from $200 at Morgan Stanley 02/17/21 Citi Citi boosts target on favorite internet stock Amazon to $3,750 AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/02/21 Amazon.com sees Q1 revenue $100B-$106B , consensus $95.69B 02/02/21 Amazon.com reports Q4 EPS $14.09, consensus $7.23 02/02/21 Notable companies reporting after market close AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 03/01/21 Amazon sued for discrimination, harassment, CNET says 03/01/21 Amazon Prime Video signs Nordics output deal with Eros STX Global, Variety says 03/01/21 Amazon picks Nader Kabbani to lead vaccine rollout, BI reports 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 02/17/21 Under Armour downgrade, Amazon target raise among top calls on Wall Street 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference AMZN Amazon.com $3,146.17 / +53.505 (+1.73%) 02/02/21 Amazon options imply 7.6% move in share price post-earnings 12/31/20 Unusually active option classes on open December 31st 12/29/20 Unusually active option classes on open December 29th 10/26/20 Early notable gainers among liquid option names on October 26th
Recommendations	Enviva price target raised to $52 from $43 at Citi » 06:17 03/02/21 03/02 06:17 03/02/21 06:17 EVA Enviva $52.17 / -0.87 (-1.64%) Citi analyst Ryan Levine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings EVA Enviva $52.17 / -0.87 (-1.64%) 02/24/21 Enviva Partners sees FY21 adjusted EBITDA $160M-$180M 02/17/21 Enviva targets net-zero operations by 2030 12/21/20 Enviva, GoChain announce results of pilot for sustainable biomass traceability 11/04/20 Enviva sees Q4 net income, adjusted EBITDA a 'significant step up' vs. Q3 EVA Enviva $52.17 / -0.87 (-1.64%) 02/26/21 RBC Capital Enviva price target raised to $60 from $51 at RBC Capital 02/26/21 Barclays Enviva price target raised to $61 from $52 at Barclays 11/11/20 RBC Capital Enviva price target raised to $51 from $46 at RBC Capital 06/24/20 Raymond James Enviva price target raised to $42 from $38 at Raymond James EVA Enviva $52.17 / -0.87 (-1.64%) 02/24/21 Enviva Partners reports Q4 EPS (24c), consensus 54c 11/04/20 Enviva reaffirms FY20 net income view $33.9M-$43.9M 11/04/20 Enviva reports Q3 revenue $225.6M, consensus $254.47M

Upgrade	Bank of Montreal upgraded to Buy from Neutral at BofA » 06:16 03/02/21 03/02 06:16 03/02/21 06:16 BMO Bank of Montreal $83.89 / +2.295 (+2.81%) BofA analyst Ebrahim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals BMO Bank of Montreal $83.89 / +2.295 (+2.81%) 10/02/20 Bank of Montreal announces 1-for-20 reverse split of NRGU ETNs BMO Bank of Montreal $83.89 / +2.295 (+2.81%) 06:04 Today BofA Bank of Montreal upgraded to Buy from Neutral at BofA 02/25/21 Desjardins Bank of Montreal price target raised to C$111 from C$100 at Desjardins 02/24/21 Canaccord Bank of Montreal price target raised to C$112.50 from C$106.50 at Canaccord 02/24/21 National Bank Bank of Montreal price target raised to C$113 from C$102 at National Bank BMO Bank of Montreal $83.89 / +2.295 (+2.81%) 02/23/21 Bank of Montreal reports Q1 adjusted EPS C$3.06 vs. C$2.41 last year 12/01/20 Bank of Montreal reports Q4 adj. EPS C$2.41 vs. C$2.43 last year BMO Bank of Montreal $83.89 / +2.295 (+2.81%) 02/03/21 USA Rare Earth exploring New York listing, WSJ reports
Recommendations	ProPetro Holding price target raised to $14 from $9 at Citi » 06:16 03/02/21 03/02 06:16 03/02/21 06:16 PUMP ProPetro Holding $12.03 / +0.5 (+4.34%) Citi analyst Scott Gruber… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PUMP ProPetro Holding $12.03 / +0.5 (+4.34%) 02/23/21 ProPetro Holding says is well positioned to benefit from increasing activity 01/20/21 ProPetro Holding still sees FY21 CapEx below $85M, investing in lower emissions 12/21/20 ProPetro names Adam Munoz to succeed David Sledge as COO 12/15/20 RigNet extends contract with ProPetro Services PUMP ProPetro Holding $12.03 / +0.5 (+4.34%) 01/25/21 B. Riley Securities ProPetro Holding price target raised to $9.50 from $6.50 at B. Riley Securities 01/11/21 Wolfe Research ProPetro Holding downgraded to Underperform from Peer Perform at Wolfe Research 12/24/20 Piper Sandler ProPetro Holding price target raised to $8 from $5 at Piper Sandler 12/18/20 JPMorgan ProPetro Holding price target raised to $10 from $6 at JPMorgan PUMP ProPetro Holding $12.03 / +0.5 (+4.34%) 02/23/21 ProPetro Holding reports Q4 EPS (44c), consensus (18c) 01/20/21 ProPetro Holding sees Q4 revenue $151M-$157M, consensus $149.21M 01/20/21 ProPetro Holding sees Q4 revenue $151M-$157M, consensus $149.21M 11/02/20 ProPetro Holding reports Q3 EPS (29c), consensus (25c) PUMP ProPetro Holding $12.03 / +0.5 (+4.34%) 02/23/21 Fly Intel: After-Hours Movers
Initiation	Terns Pharmaceuticals initiated with an Outperform at Cowen » 06:16 03/02/21 03/02 06:16 03/02/21 06:16 TERN Terns Pharmaceuticals $24.21 / +1.38 (+6.04%) Cowen analyst Ritu Baral… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly TERN Terns Pharmaceuticals $24.21 / +1.38 (+6.04%) 05:11 Today Goldman Sachs Terns Pharmaceuticals initiated with a Buy at Goldman Sachs 05 Feb TERN Terns Pharmaceuticals $24.21 / +1.38 (+6.04%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech
Periodicals	Ant Group's Jing promises eventual IPO, WSJ reports » 06:15 03/02/21 03/02 06:15 03/02/21 06:15 BABA Alibaba $241.53 / +3.44 (+1.44%) Ant Group Executive… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BABA Alibaba $241.53 / +3.44 (+1.44%) 02/16/21 Third Point buys Upstart, exits Caesars in Q4 02/03/21 Alibaba announces proposed offering of senior unsecured notes 01/20/21 Best Inc up 12% in pre-market, considering sale as part of its strategic review 01/08/21 Bill Miller sees little impact on Alibaba cash flow from regulation BABA Alibaba $241.53 / +3.44 (+1.44%) 02/23/21 Credit Suisse Farfetch price target raised to $85 from $53 at Credit Suisse 02/03/21 Raymond James Alibaba price target raised to $350 from $330 at Raymond James 02/03/21 Mizuho Alibaba price target raised to $285 from $270 at Mizuho 02/03/21 Macquarie Alibaba price target raised to $395 from $387 at Macquarie BABA Alibaba $241.53 / +3.44 (+1.44%) 02/02/21 Alibaba reports Q3 EPS $3.38, consensus $3.25 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open 11/05/20 Alibaba reports Q2 adjusted EPS $2.65, consensus $2.11 BABA Alibaba $241.53 / +3.44 (+1.44%) 02/21/21 Alibaba, Pinduoduo join fight against looming China food crisis, Bloomberg says 02/16/21 ByteDance looks to list Douyin in NY as Biden sets new mood, SCMP reports 02/12/21 Coupang IPO could take place as soon as March, WSJ reports 02/03/21 Ant, Chinese regulators reach agreement on overhaul, Bloomberg says BABA Alibaba $241.53 / +3.44 (+1.44%) 02/28/21 Opening Day: Coinbase files to go public 02/21/21 Opening Day: Podcast app developer Auddia makes public debut 02/14/21 Opening Day: Bumble, Viant soar in market debuts 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference BABA Alibaba $241.53 / +3.44 (+1.44%) 01/08/21 Notable open interest changes for January 8th 12/31/20 Notable open interest changes for December 31st 12/30/20 Unusually active option classes on open December 30th 12/30/20 Notable open interest changes for December 30th
Recommendations	ChemoCentryx price target raised to $101 from $83 at H.C. Wainwright » 06:15 03/02/21 03/02 06:15 03/02/21 06:15 CCXI ChemoCentryx $68.79 / +0.89 (+1.31%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CCXI ChemoCentryx $68.79 / +0.89 (+1.31%) 02/24/21 ChemoCentryx appoints Tausif Butt as EVP, COO 02/17/21 ChemoCentryx ADVOCATE ph.3 study of avacopan meets both endpoints 12/29/20 ChemoCentryx director sells 25K shares of common stock 12/21/20 ChemoCentryx provides topline results from ACCOLADE trial of avacopan CCXI ChemoCentryx $68.79 / +0.89 (+1.31%) 03/01/21 Stifel ChemoCentryx initiated with a Buy at Stifel 12/22/20 Piper Sandler Piper names ChemoCentryx a top pick for 2021, boosts target to $80 11/03/20 Piper Sandler Piper confident in U.S. and EU approvals for ChemoCentryx's avacopan 10/29/20 Fly Intel: Top five analyst downgrades CCXI ChemoCentryx $68.79 / +0.89 (+1.31%) 03/01/21 ChemoCentryx reports Q4 EPS (43c), consensus (33c) 11/09/20 ChemoCentryx reports Q3 EPS (35c), consensus (31c) 11 Jun CCXI ChemoCentryx $68.79 / +0.89 (+1.31%) 12/21/20 Fly Intel: After-Hours Movers 10/29/20 Fly Intel: Pre-market Movers 10/28/20 Fly Intel: After-Hours Movers 07/07/21 PDUFA Date for Avacopan

Downgrade	Athenex downgraded to Perform from Outperform at Oppenheimer » 06:14 03/02/21 03/02 06:14 03/02/21 06:14 ATNX Athenex $5.47 / -6.715 (-55.11%) Oppenheimer downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ATNX Athenex $5.47 / -6.715 (-55.11%) 03/01/21 Athenex trading resumes 03/01/21 Athenex expects cash to fund operations into 2Q22 03/01/21 Athenex announces key anticipated future milestones 03/01/21 FDA requests new study from Athenex for oral paclitaxel plus encequidar ATNX Athenex $5.47 / -6.715 (-55.11%) 05:37 Today Truist Athenex downgraded to Hold from Buy at Truist 03/01/21 JPMorgan JPMorgan downgrades Athenex on 'huge surprise' from FDA 03/01/21 SVB Leerink Athenex downgraded to Market Perform from Outperform at SVB Leerink 03/01/21 JPMorgan Athenex downgraded to Neutral from Overweight at JPMorgan ATNX Athenex $5.47 / -6.715 (-55.11%) 03/01/21 Athenex reports Q4 adjusted EPS (43c), consensus (44c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c) 10 Sep ATNX Athenex $5.47 / -6.715 (-55.11%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Pre-market Movers
Hot Stocks	CareTrust REIT acquires four California CCRCs in Southern California » 06:13 03/02/21 03/02 06:13 03/02/21 06:13 CTRE CareTrust REIT $22.82 / +0.59 (+2.65%) , MAR Marriott $148.22 / +0.11 (+0.07%) CareTrust REIT (CTRE)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CTRE MAR CTRE CareTrust REIT $22.82 / +0.59 (+2.65%) 12/17/20 CareTrust REIT reports Q4 collections of 99.7% 11/17/20 CareTrust REIT acquires four post-acute care facilities in Texas for $47.6M 09/02/20 CareTrust REIT expands in Montana MAR Marriott $148.22 / +0.11 (+0.07%) 02/25/21 Marriott CFO sells 25K shares of common stock 02/23/21 Marriott names Anthony Capuano as new CEO 02/23/21 Marriott names Anthony Capuano as new CEO 02/18/21 Marriott: Hotel owners sticking to payment plans CTRE MAR CTRE CareTrust REIT $22.82 / +0.59 (+2.65%) 01/19/21 Barclays CareTrust REIT price target raised to $25 from $21 at Barclays 01/13/21 Mizuho CareTrust REIT price target raised to $22 from $19 at Mizuho 01/07/21 BMO Capital CareTrust REIT upgraded to Outperform from Market Perform at BMO Capital 12/14/20 KeyBanc CareTrust REIT upgraded to Overweight from Sector Weight at KeyBanc MAR Marriott $148.22 / +0.11 (+0.07%) 02/24/21 Stifel American Airlines price target raised to $20 from $14 at Stifel 02/22/21 Wells Fargo Marriott price target raised to $154 from $147 at Wells Fargo 02/22/21 Wells Fargo Wells Fargo strategist upgrades Consumer Services sector to Overweight 02/22/21 Evercore ISI Evercore ISI upgrades C-Corp lodging laggard Marriott to Outperform CTRE MAR CTRE CareTrust REIT $22.82 / +0.59 (+2.65%) 02/10/21 CareTrust REIT sees FY21 normalized FFO $1.40-$1.42, consensus $1.45 02/10/21 CareTrust REIT reports Q4 normalized FFO 36c, consensus 36c MAR Marriott $148.22 / +0.11 (+0.07%) 02/18/21 Marriott reports Q4 adjusted EPS 12c, consensus 11c 02/17/21 Notable companies reporting before tomorrow's open 02/17/21 Notable companies reporting before tomorrow's open 11/06/20 Marriott reports Q3 adjusted EPS 6c, consensus (8c) MAR MAR Marriott $148.22 / +0.11 (+0.07%) 02/17/21 Linnartz, Capuano seen as frontrunners for Marriott CEO role, WSJ reports 01/11/21 JPMorgan, Citi to halt all PAC donations, WSJ reports 01/10/21 Marriott suspends donations to Senators who opposed vote result, Bloomberg says 12/15/20 Marriott permanently cuts over 800 jobs at Times Square hotel, NY Post says MAR MAR Marriott $148.22 / +0.11 (+0.07%) 12/15/20 Wells Fargo upgrade, Dick's Sporting initiation among top calls on Wall Street 11/19/20 Target, Shopify upgrades among today's top calls on Wall Street 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 11/06/20 Fly Intel: Pre-market Movers MAR MAR Marriott $148.22 / +0.11 (+0.07%) 12/29/20 Early notable gainers among liquid option names on December 29th 12/21/20 Marriott put volume heavy and directionally bearish 11/12/20 Marriott put volume heavy and directionally bearish 10/26/20 Marriott put volume heavy and directionally bearish
Recommendations	Chiasma price target raised to $12 from $10 at H.C. Wainwright » 06:13 03/02/21 03/02 06:13 03/02/21 06:13 CHMA Chiasma $3.95 / +0.055 (+1.41%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CHMA Chiasma $3.95 / +0.055 (+1.41%) 01/19/21 Chiasma appoints John Doyle as CFO 01/06/21 Chiasma provides update, sees FY21 operating expenses $80M-90M 11/20/20 Chiasma to host panel on acromegaly, MPOWERED Phase 3 trial results 11/18/20 Chiasma says MPOWERED Phase 3 trial met primary non-inferiority endpoint CHMA Chiasma $3.95 / +0.055 (+1.41%) 01/11/21 Piper Sandler Chiasma price target lowered to $15 from $19 at Piper Sandler 11/05/20 Piper Sandler Chiasma reports first Mycapssa sales, strong cash balance, says Piper Sandler 08/31/20 Piper Sandler Piper sees strong demand for Chiasma's oral acromegaly therapy 08/13/20 Jefferies Chiasma initiated with a Buy at Jefferies CHMA Chiasma $3.95 / +0.055 (+1.41%) 11/05/20 Chiasma reports Q3 EPS (30c), consensus (39c) 01 Jul 03/04/21 Chiasma - CHMA
Recommendations	Procter & Gamble removed from the US 1 List at BofA 06:12 03/02/21 03/02 06:12 03/02/21 06:12 PG Procter & Gamble $124.25 / +0.75 (+0.61%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PG Procter & Gamble $124.25 / +0.75 (+0.61%) 02/12/21 Trian Fund exits nVent, increases stake in GE 01/22/21 Procter & Gamble licenses nasal swab to Rhinostics for Covid test 01/21/21 Cerner appoints Marck Erceg as CFO 01/20/21 Procter & Gamble says innovating, bringing new products to market PG Procter & Gamble $124.25 / +0.75 (+0.61%) 01/28/21 Stifel Stifel downgrades Procter & Gamble to Hold on emerging headwinds 01/28/21 Stifel Procter & Gamble downgraded to Hold from Buy at Stifel 01/19/21 Bernstein Procter & Gamble initiated with a Market Perform at Bernstein 01/13/21 Deutsche Bank Procter & Gamble price target raised to $159 from $156 at Deutsche Bank PG Procter & Gamble $124.25 / +0.75 (+0.61%) 01/20/21 Procter & Gamble raises FY21 core EPS view to up 8%-10% from up 5%-8% 01/20/21 Procter & Gamble reports Q2 core EPS $1.64, consensus $1.51 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open PG Procter & Gamble $124.25 / +0.75 (+0.61%) 11/13/20 Procter & Gamble new disinfectant on pace for $200M in sales, WSJ reports 10/13/20 P&G investors approve proposal for deforestation report, Bloomberg says PG Procter & Gamble $124.25 / +0.75 (+0.61%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/20/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: Pre-market Movers 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street PG Procter & Gamble $124.25 / +0.75 (+0.61%) 02/26/21 Unusually active option classes on open February 26th 12/09/20 Notable open interest changes for December 9th 10/20/20 Unusually active option classes on open October 20th
Periodicals	Tailored Brands nears $75M loan after bankruptcy exit, WSJ reports » 06:12 03/02/21 03/02 06:12 03/02/21 06:12 TLRD Tailored Brands $0.00 / + (+0.00%) Tailored Brands Inc., the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research TLRD Tailored Brands $0.00 / + (+0.00%) 12/02/20 Tailored Brands completes financial restructuring, emerges from Chapter 11 TLRD Tailored Brands $0.00 / + (+0.00%) 03/19/20 Deutsche Bank Tailored Brands price target lowered to $1 from $4 at Deutsche Bank

Recommendations	Dentsply Sirona price target raised to $60 from $55 at H.C. Wainwright » 06:11 03/02/21 03/02 06:11 03/02/21 06:11 XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 01/04/21 Dentsply Sirona acquires Byte in $1.04B all-cash deal 01/04/21 Dentsply Sirona acquires Byte in $1.04B all cash deal XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Piper Sandler Dentsply Sirona price target raised to $70 from $63 at Piper Sandler 02/09/21 Stifel Dentsply Sirona checks point to potential channel conflict, says Stifel 01/08/21 Credit Suisse Envista upgraded to Outperform from Neutral at Credit Suisse 01/05/21 Baird Dentsply Sirona price target raised to $62 from $58 at Baird XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Dentsply Sirona sees FY21 adjusted EPS $2.60-$2.80, consensus $2.39 03/01/21 Dentsply Sirona reports Q4 adjusted EPS 87c, consensus 64c 11/05/20 Dentsply Sirona reports Q3 non-GAAP EPS 67c, consensus 32c 11/04/20 Notable companies reporting before tomorrow's open XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Fly Intel: Pre-market Movers 11/05/20 Fly Intel: Pre-market Movers XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Early notable gainers among liquid option names on March 1st 10/22/20 Early notable gainers among liquid option names on October 22nd
Initiation	Darling Ingredients initiated with an Overweight at Piper Sandler » 06:10 03/02/21 03/02 06:10 03/02/21 06:10 DAR Darling Ingredients $64.07 / +1.005 (+1.59%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DAR Darling Ingredients $64.07 / +1.005 (+1.59%) 01/28/21 Darling Ingredients, Valero joint venture receives approval for Texas facility 10/27/20 Darling Ingredients' joint venture receives air permit from TCEQ DAR Darling Ingredients $64.07 / +1.005 (+1.59%) 01/29/21 Baird Darling Ingredients price target raised to $71 from $50 at Baird 01/27/21 JPMorgan Darling Ingredients price target raised to $69 from $48 at JPMorgan 11/05/20 BMO Capital Darling Ingredients price target raised to $46 from $33 at BMO Capital 10/22/20 Roth Capital Darling Ingredients price target raised to $84 from $38 at Roth Capital DAR Darling Ingredients $64.07 / +1.005 (+1.59%) 11/03/20 Darling Ingredients reports Q3 GAAP EPS 61c, consensus 44c 03/15/21 33rd Annual Roth Virtual Conference 03/18/21 Waste & Environmental Services Virtual Symposium 03/03/21 Darling Ingredients - DAR
Hot Stocks	Kaixin Auto announces Haitaoche's subsidiaries new vehicle sales contracts » 06:10 03/02/21 03/02 06:10 03/02/21 06:10 KXIN Kaixin Auto $3.49 / +0.11 (+3.25%) Kaixin Auto Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly Options KXIN Kaixin Auto $3.49 / +0.11 (+3.25%) 01/11/21 Kaixin Auto: Haitaoche enters five-year vehicles supply contract with CVC 01/04/21 Kaixin Auto enters share purchase agreement with Haitaoche shareholders 11/05/20 Kaixin Auto CEO Chen Ji, COO Jinfeng Xie resign from positions 11/05/20 Kaixin Auto enters binding term sheet for Haitaoche merger KXIN Kaixin Auto $3.49 / +0.11 (+3.25%) 11/05/20 Fly Intel: Wall Street's top stories at midday 11/05/20 Fly Intel: Pre-market Movers KXIN Kaixin Auto $3.49 / +0.11 (+3.25%) 11/16/20 Sixteen new option listings and one option delisting on November 16th
Periodicals	Frontier Airlines cancels flight after passengers refuse to wear masks, NYT says » 06:10 03/02/21 03/02 06:10 03/02/21 06:10 FRNTQ Frontier Airlines $0.00 / + (+0.00%) Frontier Airlines… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	F5 Networks price target raised to $223 from $216 at Piper Sandler » 06:09 03/02/21 03/02 06:09 03/02/21 06:09 FFIV F5 Networks $194.05 / +3.92 (+2.06%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FFIV F5 Networks $194.05 / +3.92 (+2.06%) 02/16/21 Elliott buys Evergy, exits eBay in Q4 01/07/21 F5 Networks jumps 3% to $186 after confirming Volterra acquisition 01/07/21 F5 Networks raises long-term revenue growth view to double digits 01/07/21 F5 Networks confirms $500M acquisition of Volterra FFIV F5 Networks $194.05 / +3.92 (+2.06%) 01/27/21 RBC Capital F5 Networks price target raised to $200 from $182 at RBC Capital 01/27/21 Piper Sandler F5 Networks price target raised to $216 from $205 at Piper Sandler 01/25/21 Cowen F5 Networks price target raised to $255 from $223 at Cowen 01/14/21 Barclays F5 Networks price target raised to $235 from $212 at Barclays FFIV F5 Networks $194.05 / +3.92 (+2.06%) 01/26/21 F5 Networks sees Q2 adjusted EPS $2.32-$2.44, consensus $2.41 01/26/21 F5 Networks reports Q1 adjusted $2.59, consensus $2.46 01/07/21 F5 Networks sees Q1 EPS above top end of prior $2.26-$2.38, consensus $2.34 10/26/20 F5 Networks sees Q1 adjusted EPS $2.26-$2.38, consensus $2.28 FFIV F5 Networks $194.05 / +3.92 (+2.06%) 01/07/21 F5 Networks near deal to buy Volterra for $500M, Bloomberg says 12/17/20 Nuclear weapons agency breached amid massive espionage operation, Politico says 11/08/20 Elliot Management takes stakes in F5 Networks, WSJ reports FFIV F5 Networks $194.05 / +3.92 (+2.06%) 01/26/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: After-Hours Movers 10/26/20 Fly Intel: After-Hours Movers 03/11/21 F5 Networks Inc. FFIV F5 Networks $194.05 / +3.92 (+2.06%) 01/08/21 Early notable gainers among liquid option names on January 8th 10/27/20 Early notable gainers among liquid option names on October 27th

Hot Stocks	Yatsen to acquire Eve Lom from Manzanita Capital, terms undisclosed » 06:09 03/02/21 03/02 06:09 03/02/21 06:09 YSG Yatsen $18.63 / +1.055 (+6.00%) Yatsen announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options YSG Yatsen $18.63 / +1.055 (+6.00%) 12/29/20 Yatsen and Sensient enter into a strategic collaboration 11/30/20 Tiger Global reports 6.6% passive stake in Yatsen YSG Yatsen $18.63 / +1.055 (+6.00%) 12/14/20 Morgan Stanley Yatsen initiated with an Equal Weight at Morgan Stanley 12/13/20 Goldman Sachs Yatsen initiated with a Neutral at Goldman Sachs YSG Yatsen $18.63 / +1.055 (+6.00%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 19 Nov YSG Yatsen $18.63 / +1.055 (+6.00%) 11/22/20 Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO YSG Yatsen $18.63 / +1.055 (+6.00%) 12/16/20 Eight new option listings and one option delisting on December 16th
Upgrade	Hims & Hers upgraded to Buy from Neutral at Citi » 06:09 03/02/21 03/02 06:09 03/02/21 06:09 HIMS Hims & Hers $15.26 / +0.65 (+4.45%) Citi analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Events Options HIMS Hims & Hers $15.26 / +0.65 (+4.45%) 02/24/21 Hims & Hers falls -9.4% 02/01/21 Conversion Labs up 15% after Citron discloses long position 01/28/21 Hims & Hers rises 24.0% 01/28/21 Hims & Hers rises 30.6% HIMS Hims & Hers $15.26 / +0.65 (+4.45%) 02/17/21 Citi Hims & Hers initiated with a Neutral at Citi 02/12/21 Fly Intel: Top five analyst initiations 02/12/21 Piper Sandler Hims & Hers initiated with a Neutral at Piper Sandler 02/08/21 Tigress Financial Hims & Hers initiated with a Buy at Tigress Financial HIMS Hims & Hers $15.26 / +0.65 (+4.45%) 02/01/21 Citron long Conversion Labs, says 'would be at $140' with Hims & Hers' multiple 01/12/21 A-Rod and J-Lo investors in SPAC target Hims & Hers, Sportico says 03/24/21 Hims & Hers HIMS Hims & Hers $15.26 / +0.65 (+4.45%) 01/21/21 Eighteen new option listings and one option delisting on January 21st
Initiation	Angion Biomedica initiated with an Outperform at Cowen » 06:08 03/02/21 03/02 06:08 03/02/21 06:08 ANGN Angion Biomedica $19.85 / +2.6 (+15.07%) Cowen analyst Marc Frahm… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly ANGN Angion Biomedica $19.85 / +2.6 (+15.07%) 03/01/21 H.C. Wainwright Angion Biomedica initiated with a Buy at H.C. Wainwright 05 Feb ANGN Angion Biomedica $19.85 / +2.6 (+15.07%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech
Recommendations	Splunk may see 'slight upside' in Q4 results, says RBC Capital » 06:08 03/02/21 03/02 06:08 03/02/21 06:08 SPLK Splunk $151.21 / +8.2 (+5.73%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SPLK Splunk $151.21 / +8.2 (+5.73%) 02/08/21 Splunk, McLaren Racing announce multi-year formula 1 partnership extension 12/02/20 Splunk CFO says close rates for several large deal slowed in final weeks of Q3 12/02/20 Splunk extends afterhours decline to 17% after pulling medium-term targets 12/02/20 Splunk falls 10.9% to $183.41 after downbeat Q3 results SPLK Splunk $151.21 / +8.2 (+5.73%) 02/24/21 Jefferies Jefferies remains a buyer of Splunk, sees 'favorable set-up' into earnings 02/17/21 Mizuho Splunk price target raised to $190 from $180 at Mizuho 02/11/21 Oppenheimer Splunk assumed with an Outperform at Oppenheimer 01/21/21 Goldman Sachs Splunk assumed with a Buy at Goldman Sachs SPLK Splunk $151.21 / +8.2 (+5.73%) 12/02/20 Splunk withdrawing FY23 ARR and operating cash flow targets 12/02/20 Splunk sees Q4 revenue $650M-$700M, consensus $777.73M 12/02/20 Splunk reports Q3 EPS ($1.26), consensus 9c 12/02/20 Notable companies reporting after market close SPLK Splunk $151.21 / +8.2 (+5.73%) 11/03/20 UK government in talks with Palantir about 'test-and-trace' program, FT says SPLK Splunk $151.21 / +8.2 (+5.73%) 12/29/20 Splunk initiation, Snap target change among today's top calls on Wall Street 12/03/20 Fly Intel: Wall Street's top stories for Thursday 12/03/20 Fly Intel: Wall Street's top stories at midday 12/03/20 Splunk dives, Wall Street analysts flee after 'disappointing' earnings, outlook 03/03/21 Splunk - SPLK SPLK Splunk $151.21 / +8.2 (+5.73%) 12/23/20 Splunk call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/21/20 Splunk call volume above normal and directionally bullish 12/07/20 Unusually active option classes on open December 7th
Hot Stocks	Axonics enters strategic alliance with Micro Systems Technologies » 06:07 03/02/21 03/02 06:07 03/02/21 06:07 AXNX Axonics $53.37 / +2.98 (+5.91%) Axonics announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AXNX Axonics $53.37 / +2.98 (+5.91%) 02/25/21 Axonics to acquire Bulkamid for $200M 02/16/21 Axonics receives PMA supplement approval from FDA for its INS 11/10/20 Axonics publishes fecal incontinence study results 10/29/20 Axonics submits PMA supplement to FDA to expand MRI labeling AXNX Axonics $53.37 / +2.98 (+5.91%) 01/26/21 Baird Axonics price target raised to $65 from $58 at Baird 01/26/21 Piper Sandler Axonics price target raised to $64 from $57 at Piper Sandler 01/07/21 Morgan Stanley Axonics price target raised to $58 from $53 at Morgan Stanley 12/01/20 BofA ShockWave Medical downgraded to Neutral from Buy at BofA AXNX Axonics $53.37 / +2.98 (+5.91%) 02/25/21 Axonics reports Q4 EPS (29c), consensus (31c) 01/25/21 Axonics sees Q4 revenue $34.7M-$34.9M, consensus $35.48M 11/04/20 Axonics reports Q3 EPS (24c), consensus (50c) 08 May AXNX Axonics $53.37 / +2.98 (+5.91%) 11/04/20 Fly Intel: After-Hours Movers

Events

Earnings calls, analyst events, roadshows and more

AMADY
Today at 07:30

Amadeus IT Group - AMADY Conference Calls
SE
Today at 07:30

Sea Limited - SE Conference Calls
FOE
Today at 08:00

Ferro - FOE Conference Calls
LMND
Today at 08:00

Lemonade - LMND Conference Calls
MBI
Today at 08:00

MBIA - MBI Conference Calls
CHS
Today at 08:00

Chico's - CHS Conference Calls
TILE
Today at 08:00

Interface - TILE Conference Calls
LL
Today at 08:00

Lumber Liquidators - LL Conference Calls
IGT
Today at 08:00

International Game - IGT Conference Calls
FSK
Today at 08:00

FS KKR Capital - FSK Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley $84.00-84.50 1.2M Shares KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan $124.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley $11.88-12.00 30M Shares FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley $166.50-169.95 1.5M Shares HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan $88.25-89.25 1.45M Shares JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs $30.60 7M Shares RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 12M Shares OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $32.00-34.00 31M Shares ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: Wells Fargo, Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

CIBC still sees Whitecap as preferred stock in Canadian mid-cap oil space

TODAY'S FREE FLY STORIES

Get Full Fly Access